Lilly/Verge Pact Shows Resistance To Biopharma AI Is Futile

AI hand reaches
Eli Lilly and Verge announced a drug discovery and development deal centered on amyotrophic lateral sclerosis • Source: Shutterstock

More from Deals

More from Business